Abstract:Strain NJES-13(T) is the type strain and currently the only species of the newly established actinobacteria genera Aptenodytes in the family Dermatophilaceae isolated from the gut microbiota of the Antarctic emperor penguin. This strain demonstrated excellent bioflocculation activity with bacteria-derived exopolysaccharides (EPSs). Moreover, it produced bioactive angucycline/angucyclinone derivatives (ADs) and contained one type III polyketide synthase (T3PKS), thus demonstrating great potential to produce novel bioactive compounds. However, the low productivity of the potential new AD metabolite was the main obstacle for its chemical structure elucidation. In this study, to increase the concentration of targeted metabolites, the influence of cellular morphology on AD metabolism in strain NJES-13(T) was determined using glass bead-enhanced fermentation. Based on the cellular ultra-structural observation driven by bacterial EPSs, and quantitative analysis of the targeted metabolites, the successful increasing of the productivity of three AD metabolites was achieved. Afterward, a new frigocyclinone analogue was isolated and then identified as 2-hydroxy-frigocyclinone, as well as two other known ADs named 2-hydroxy-tetrangomycin (2-HT) and gephyromycin (GPM). Three AD metabolites were found to demonstrate different bioactivities. Both C-2 hydroxyl substitutes, 2-hydroxy-tetrangomycin and 2-hydroxy-frigocyclinone, exhibited variable inhibitory activities against Staphylococcus aureus, Bacillus subtilis and Candida albicans. Moreover, the newly identified 2-hydroxy-frigocyclinone also showed significant cytotoxicity against three tested human-derived cancerous cell lines (HL-60, Bel-7402 and A549), with all obtained IC50 values less than 10 mu M. Based on the genetic analysis after genomic mining, the plausible biogenetic pathway of the three bioactive ADs in strain NJES-13(T) was also proposed.

Gephyyamycin and Cysrabelomycin, Two New Angucyclinone Derivatives from the Streptomyces Sp. HN-A124

Two New P-Methoxyphenyl-type Derivatives from a Saline-Lake Derived Streptomyces Sp. XZB32.

Cytotoxic Bafilomycin Analogues 6/5/5 with Tricyclic Ring System from a Marine-Derived Streptomyces Sp

Cytotoxic and Antibacterial Angucycline- and Prodigiosin- Analogues from the Deep-Sea Derived Streptomyces sp. SCSIO 11594

Monacycliones G-K and Ent-Gephyromycin A, Angucycline Derivatives from the Marine-Derived Streptomyces Sp. HDN15129.

Angucycline Glycosides from an Intertidal Sediments Strain Streptomyces sp. and Their Cytotoxic Activity against Hepatoma Carcinoma Cells

Cytotoxic Antibiotic Angucyclines and Actinomycins from the Streptomyces Sp. XZHG99T

Angucyclines and Angucyclinones from Streptomyces Sp. CB01913 Featuring C-Ring Cleavage and Expansion.

Cytotoxic gephyromycins from the Streptomyces sp. SS13I

Cytotoxic Angucyclines Fromamycolatopsissp. HCa1, a Rare Actinobacteria Derived Fromoxya Chinensis

Antibacterial Angucyclinone and Α-Pyrone Derivatives from Desert-Derived Nocardiopsis Dassonvillei HDN 154151

ChemInform Abstract: Angucyclines from an Insect‐Derived Actinobacterium Amycolatopsis Sp. HCa1 and Their Cytotoxic Activity.

Antibiotic Angucycline Derivatives from the Deepsea-Derived Streptomyces Lusitanus

Kiamycin, A Unique Cytotoxic Angucyclinone Derivative From A Marine Streptomyces Sp.

Nitricquinomycins A-C, Uncommon Naphthopyrrolediones from the Streptomyces Sp. ZS-A45

Characterization of Bioactivities and Biosynthesis of Angucycline/Angucyclinone Derivatives Derived from <i>Gephyromycinifex aptenodytis</i> gen. nov., sp. nov.

Two glucosylated angucyclines from deep-sea-derived Streptomyces sp.PKU-MA01297

Cangumycins A-F, Six New Angucyclinone Analogues with Immunosuppressive Activity from Streptomyces.

Angucycline antibiotics and its derivatives from marine-derived actinomycete Streptomyces sp. A6H

Characterization of Bioactivities and Biosynthesis of Angucycline/Angucyclinone Derivatives Derived from Gephyromycinifex aptenodytis gen. nov., sp. nov.

Grincamycins I - K, Cytotoxic Angucycline Glycosides Derived from Marine-Derived Actinomycete Streptomyces lusitanus SCSIO LR32.